BioMerieux - 20 Year Stock Price History | BMXMF
Historical daily share price chart and data for BioMerieux since 2005 adjusted for splits and dividends. The latest closing stock price for BioMerieux as of May 15, 2025 is 129.73.
- The all-time high BioMerieux stock closing price was 163.26 on October 12, 2020.
- The BioMerieux 52-week high stock price is 136.40, which is 5.1% above the current share price.
- The BioMerieux 52-week low stock price is 93.50, which is 27.9% below the current share price.
- The average BioMerieux stock price for the last 52 weeks is 116.72.
| BioMerieux Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 123.2648 | 103.5000 | 132.2900 | 103.5000 | 129.7320 | 22.17% |
| 2024 | 107.6323 | 107.5670 | 122.5240 | 93.5000 | 106.1900 | -1.25% |
| 2023 | 101.5146 | 101.4150 | 110.0840 | 90.8027 | 107.5320 | 3.29% |
| 2022 | 100.0412 | 139.8330 | 139.8330 | 76.9557 | 104.1070 | -23.61% |
| 2021 | 124.4042 | 140.5370 | 152.0430 | 102.8430 | 136.2800 | 2.03% |
| 2020 | 130.3426 | 85.8741 | 163.2590 | 84.5226 | 133.5660 | 55.54% |
| 2019 | 78.7123 | 58.1240 | 88.4808 | 58.1240 | 85.8741 | 37.51% |
| 2018 | 79.4734 | 87.4625 | 92.0633 | 59.0847 | 62.4473 | -25.60% |
| 2017 | 75.3090 | 50.8897 | 84.4113 | 50.0682 | 83.9330 | 81.68% |
| 2016 | 42.3169 | 36.5113 | 48.8312 | 35.9298 | 46.1985 | 24.60% |
| 2015 | 33.4860 | 31.4713 | 37.0767 | 27.7753 | 37.0767 | 18.06% |
| 2014 | 31.7479 | 31.0558 | 34.1825 | 29.8952 | 31.4050 | 3.53% |
| 2013 | 28.3500 | 26.9831 | 30.3328 | 26.8380 | 30.3328 | 10.05% |
| 2012 | 25.8192 | 24.1774 | 27.7810 | 23.3328 | 27.5634 | -16.10% |
| 2011 | 31.0356 | 30.6853 | 32.8520 | 29.5694 | 32.8520 | 20.17% |
| 2010 | 27.4957 | 26.1561 | 30.4063 | 26.0825 | 27.3378 | -11.41% |
| 2009 | 26.1291 | 21.0395 | 30.8599 | 21.0395 | 30.8599 | 39.18% |
| 2008 | 24.5321 | 26.8909 | 26.8909 | 22.1732 | 22.1732 | 1.23% |
| 2007 | 20.5558 | 19.2078 | 21.9038 | 19.2078 | 21.9038 | 27.19% |
| 2006 | 15.7832 | 14.1078 | 17.2208 | 14.1078 | 17.2208 | 27.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.355B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |